A trial of diphenylhydantoin in periodic disease (familial Mediterranean fever) in Egyptian children.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Familial mediterranean fever is a childhood disease which usually starts around the age of 4 years. Its onset is insidious with common and misleading symptoms such as fever and abdominal pain. Accordingly, this disease is often recognized belatedly from evocative data from previous history such as the recurrence of attacks, familial descent from certain ethnic groups and the lack of other obvious etiology. The clinical picture within this age group is similar to that observed in adults and does not present any clinical or biological originality. Colchicine remains the only efficient treatment to prevent both acute manifestations and amyloidosis. The former is geared toward its current use among children (growth retardation and gonadic disturbances) and is not really relevant, at least in this particular disease.
Explore the source record for details and available documents.